VAMP5 promotes glioma progression through bioinformatics analysis clinical correlation and functional validation
VAMP5 promotes glioma progression and is associated with immune modulation and adverse clinical outcomes. It may serve as a novel biomarker for prognosis and a potential therapeutic target in glioma.
Authors
- Bo Li (ORCID: https://orcid.org/0000-0002-7294-6888)
- Haixin Zeng (ORCID: https://orcid.org/0009-0004-1510-8660)
- Yujie Ji
- Zhentao Liu
- Zheng Cai
- Xiangyu Dai
Institutions
- Jiangnan University (CN)
- Zhengzhou City Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1007/s12672-025-04375-1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00